ADMA Biologics Inc (ADMA)
19.13
-0.24
(-1.24%)
USD |
NASDAQ |
Nov 04, 16:00
19.11
-0.02
(-0.10%)
After-Hours: 20:00
ADMA Biologics Enterprise Value: 4.558B for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 4.558B |
| October 31, 2024 | 3.844B |
| October 30, 2024 | 3.996B |
| October 29, 2024 | 3.938B |
| October 28, 2024 | 3.872B |
| October 25, 2024 | 3.728B |
| October 24, 2024 | 3.763B |
| October 23, 2024 | 3.700B |
| October 22, 2024 | 3.695B |
| October 21, 2024 | 3.684B |
| October 18, 2024 | 3.721B |
| October 17, 2024 | 3.800B |
| October 16, 2024 | 3.875B |
| October 15, 2024 | 3.907B |
| October 14, 2024 | 3.858B |
| October 11, 2024 | 4.039B |
| October 10, 2024 | 4.008B |
| October 09, 2024 | 4.780B |
| October 08, 2024 | 4.872B |
| October 07, 2024 | 4.746B |
| October 04, 2024 | 4.772B |
| October 03, 2024 | 4.604B |
| October 02, 2024 | 4.588B |
| October 01, 2024 | 4.651B |
| September 30, 2024 | 4.702B |
| Date | Value |
|---|---|
| September 27, 2024 | 4.561B |
| September 26, 2024 | 4.574B |
| September 25, 2024 | 4.586B |
| September 24, 2024 | 4.539B |
| September 23, 2024 | 4.711B |
| September 20, 2024 | 4.700B |
| September 19, 2024 | 4.644B |
| September 18, 2024 | 4.546B |
| September 17, 2024 | 4.404B |
| September 16, 2024 | 4.285B |
| September 13, 2024 | 4.259B |
| September 12, 2024 | 4.157B |
| September 11, 2024 | 3.984B |
| September 10, 2024 | 4.073B |
| September 09, 2024 | 4.327B |
| September 06, 2024 | 3.833B |
| September 05, 2024 | 3.945B |
| September 04, 2024 | 3.975B |
| September 03, 2024 | 3.905B |
| August 30, 2024 | 4.077B |
| August 29, 2024 | 4.057B |
| August 28, 2024 | 4.061B |
| August 27, 2024 | 4.087B |
| August 26, 2024 | 4.112B |
| August 23, 2024 | 4.332B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
185.96M
Minimum
Mar 18 2020
4.872B
Maximum
Oct 08 2024
831.19M
Average
457.18M
Median
Apr 27 2022
Enterprise Value Benchmarks
| Corcept Therapeutics Inc | 4.609B |
| Assembly Biosciences Inc | -2.042M |
| TG Therapeutics Inc | 4.050B |
| Varex Imaging Corp | 806.57M |
| Krystal Biotech Inc | 4.508B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 32.06M |
| Revenue (Quarterly) | 107.19M |
| Total Expenses (Quarterly) | 67.99M |
| EPS Diluted (Quarterly) | 0.13 |
| Gross Profit Margin (Quarterly) | 53.60% |
| Profit Margin (Quarterly) | 29.91% |
| Earnings Yield | 0.73% |
| Operating Earnings Yield | 1.89% |
| Normalized Earnings Yield | 1.337 |